Victory Capital Management
TNYA icon

Victory Capital Management’s Tenaya Therapeutics TNYA Stock Holding History

Victory Capital Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Buy
18,491
+843
+5% +$622 ﹤0.01% 2389
2025
Q4 		$12.6K Buy
+17,648
New +$24K ﹤0.01% 2404
2025
Q2 		– Sell
-15,299
Closed -$8.72K – 2559
2025
Q1 		$8.72K Buy
+15,299
New +$15.1K ﹤0.01% 2460

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's TNYA Position: Q1 2026 in Review

Victory Capital Management increased its Tenaya Therapeutics (TNYA) stake by 4.8% in Q1 2026, buying an estimated $622 and bringing the position to 18,491 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2389.

Victory Capital Management first reported a position in TNYA in Q1 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Victory Capital Management held 18,491 shares of Tenaya Therapeutics worth $12.8K as of Q1 2026.
  • Victory Capital Management bought 843 Tenaya Therapeutics shares in Q1 2026, an estimated $622.
  • Tenaya Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2389 holding.
  • Victory Capital Management first reported a position in Tenaya Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.